申请人:Merck Sharp & Dohme Corp.
公开号:US20150191461A1
公开(公告)日:2015-07-09
The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
本发明提供了公式I的新型吡唑衍生物,它们是脾酪氨酸激酶的有效抑制剂,并可用于治疗和预防由该酶介导的疾病,如哮喘、慢性阻塞性肺疾病、类风湿性关节炎和癌症。